Michael N Intrator sold $27M of CRWV
CEO and President at CoreWeave, Inc.. 307,692 shares at an average of $86.82, traded Sep 22, 2026, filed Sep 24, 2026.
Score components
- +25RoleCEO
- +25Trade size$26.7M at market
- +10Share of holdings soldSold 35% of holdings
- +15Cluster8 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001769628-26-000435, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -23,231 | $85.57 | $2.0M | 863,898 | 18 d ago |
| Sep 22, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -87,341 | $86.41 | $7.5M | 776,557 | 18 d ago |
| Sep 22, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -61,489 | $87.15 | $5.4M | 715,068 | 18 d ago |
| Sep 22, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -24,428 | $88.33 | $2.2M | 690,640 | 18 d ago |
| Sep 22, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -3,511 | $88.95 | $312k | 687,129 | 18 d ago |
| Sep 22, 2026 | CConversion Class A Common Stockindirect: Omnadora Capital LLC10b5-1 | +107,692 | - | - | 107,692 | 18 d ago |
| Sep 22, 2026 | SOpen-market sale Class A Common Stockindirect: Omnadora Capital LLC10b5-1 | -12,509 | $85.57 | $1.1M | 95,183 | 18 d ago |
| Sep 22, 2026 | SOpen-market sale Class A Common Stockindirect: Omnadora Capital LLC10b5-1 | -47,025 | $86.41 | $4.1M | 48,158 | 18 d ago |
| Sep 22, 2026 | SOpen-market sale Class A Common Stockindirect: Omnadora Capital LLC10b5-1 | -33,114 | $87.15 | $2.9M | 15,044 | 18 d ago |
| Sep 22, 2026 | SOpen-market sale Class A Common Stockindirect: Omnadora Capital LLC10b5-1 | -13,154 | $88.33 | $1.2M | 1,890 | 18 d ago |
| Sep 22, 2026 | SOpen-market sale Class A Common Stockindirect: Omnadora Capital LLC10b5-1 | -1,890 | $88.95 | $168k | 0 | 18 d ago |
| Sep 22, 2026 | CConversion Class B Common Stockderivativeindirect: Omnadora Capital LLC10b5-1 | -107,692 | - | - | 22,156,972 | 18 d ago |
Related signals
Other insiders at CoreWeave, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 17Weak | CoreWeave, Inc. | Nitin Agrawal Chief Financial Officer | $266 3 shares | -0% | |
| 22Weak | CoreWeave, Inc. | Nitin Agrawal Chief Financial Officer | $438 5 shares | -0% | |
| 15Weak | CoreWeave, Inc. | Jeff Baker Principal Accounting Officer | $438 5 shares | -0% | |
| 15Weak | CoreWeave, Inc. | Chen Goldberg EVP, Product & Engineering | $438 5 shares | -0% | |
| 55Moderate | CoreWeave, Inc. | Michael N Intrator CEO and President | $6.9M 78,552 shares | -13% | |
| 20Weak | CoreWeave, Inc. | Sachin Jain Chief Operating Officer | $351 4 shares | -0% | |
| 45Moderate | CoreWeave, Inc. | Brannin McBee Chief Development Officer | $5.0M 56,531 shares | -13% | |
| 15Weak | CoreWeave, Inc. | Kristen J McVeety GC and Secretary | $438 5 shares | -0% | |
| 45Moderate | CoreWeave, Inc. | Brian M Venturo Chief Strategy Officer | $5.8M 65,616 shares | -18% | |
| 55Moderate | CoreWeave, Inc. | Michael N Intrator CEO and President | $27M 307,692 shares | -45% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.